MONEY

Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi ® (lecanemab-irmb) in the US

Tomas Kauer - ModeratorTomas Kauer - Moderator
Nov 1, 2024 - 08:00
Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi ® (lecanemab-irmb) in the US
Read More

Tags:

Previous Article

Death toll in Spain's floods rises to 158, among Europe's worst storm disasters

Next Article

BIG TREE CLOUD ANNOUNCED RESIGNATION AND APPOIN™ENT OF DIRECTORS

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

The First of Long Island Corporation Announces Third Quarter Cash Dividend of $.21 per Share

The First of Long Island Corporation Announces Third Qu...

Tomas Kauer - Mode... Oct 2, 2024

Tradeweb reports record trading volumes in September 2024

Tradeweb reports record trading volumes in September 2024

Tomas Kauer - Mode... Oct 4, 2024

Oil prices settle up on supply shocks, prospect of US interest rate cuts

Oil prices settle up on supply shocks, prospect of US i...

Tomas Kauer - Mode... Sep 18, 2024